Publications by authors named "James E Fielding"

Article Synopsis
  • - The study examines the potential impact of improved influenza vaccines on reducing illness and deaths in Australians under 65, estimating the additional morbidity and mortality that could be averted.
  • - Researchers analyzed data from 2015-2019, calculating the burden of influenza in a hypothetical unvaccinated population and using this to project benefits from standard versus improved vaccines.
  • - Findings suggest that an improved vaccine could prevent between 1,517 to 12,641 influenza cases, 287 to 1,311 hospitalizations, and 9 to 33 deaths annually, mainly when the standard vaccine is less effective.
View Article and Find Full Text PDF

Background: Household transmission investigations (HHTIs) contribute timely epidemiologic knowledge in response to emerging pathogens. HHTIs conducted in the context of the COVID-19 pandemic in 2020-21 reported variable methodological approaches, producing epidemiological estimates that vary in meaning, precision and accuracy. Because specific tools to assist with the optimal design and critical appraisal of HHTIs are not available, the aggregation and pooling of inferences from HHTIs to inform policy and interventions may be challenging.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on estimating the household secondary infection attack rate (hSAR) of SARS-CoV-2 using data from WHO protocols and involved a systematic review and meta-analysis of relevant articles published from December 2019 to July 2021.
  • Out of nearly 10,000 records, 80 articles were selected, with 62 included in the main analysis, revealing hSAR estimates that varied widely from 2% to 90%, indicating significant heterogeneity in the results.
  • The findings highlight the importance of standardizing methodologies in future investigations to improve pandemic preparedness and response for COVID-19 and other respiratory viruses.
View Article and Find Full Text PDF

Background: The Australian First Few X (FFX) Household Transmission Project for COVID-19 was the first prospective, multi-jurisdictional study of its kind in Australia. The project was undertaken as a partnership between federal and state health departments and the Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE) and was active from April to October 2020.

Methods: We aimed to identify and explore the challenges and strengths of the Australian FFX Project to inform future FFX study development and integration into pandemic preparedness plans.

View Article and Find Full Text PDF

Background: Mongolia is a vast, sparsely populated country in central Asia. Its harsh climate and nomadic lifestyle make the population vulnerable to acute respiratory infections, particularly influenza. Evidence on the morbidity, mortality and socioeconomic impact of influenza in Mongolia is scarce; however, routine surveillance for influenza-like illness (ILI), severe acute respiratory infection (SARI) and laboratory-detected influenza is conducted.

View Article and Find Full Text PDF
Article Synopsis
  • Measles and rubella elimination has been successful in some regions, but outbreaks among adults in workplaces are still occurring.
  • A study of 134 office employees found high levels of immunity, with attitudes towards vaccination significantly influencing their willingness to get immunized.
  • The research suggests that healthcare providers should educate adults about the importance of measles and rubella vaccination during routine health check-ups to increase immunization rates.
View Article and Find Full Text PDF
Article Synopsis
  • Pregnant women face a higher risk of severe illness from influenza, prompting recommendations for prioritizing their vaccination at any stage of pregnancy due to limited knowledge about timing.
  • This study aimed to assess the effect of vaccination timing on the immune response in mothers and how well antibodies are transferred to newborns.
  • Results from 16 studies indicated that women who received the vaccine in later trimesters had significantly higher immune responses and antibody levels in their newborns compared to those vaccinated earlier.
View Article and Find Full Text PDF

Background: We estimated the effectiveness of seasonal inactivated influenza vaccine and the potential influence of timing of immunization on vaccine effectiveness (VE) using data from the 2016 southern hemisphere influenza season.

Methods: Data were pooled from three routine syndromic sentinel surveillance systems in general practices in Australia. Each system routinely collected specimens for influenza testing from patients presenting with influenza-like illness.

View Article and Find Full Text PDF

Objective: Recent studies have used Bayesian methods to predict timing of influenza epidemics many weeks in advance, but there is no documented evaluation of how such forecasts might support the day-to-day operations of public health staff.

Methods: During the 2015 influenza season in Melbourne, Australia, weekly forecasts were presented at Health Department surveillance unit meetings, where they were evaluated and updated in light of expert opinion to improve their accuracy and usefulness.

Results: Predictive capacity of the model was substantially limited by delays in reporting and processing arising from an unprecedented number of notifications, disproportionate to seasonal intensity.

View Article and Find Full Text PDF

In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B.

View Article and Find Full Text PDF

The Victorian Sentinel Practice Influenza Network conducts syndromic surveillance for influenza-like illness (ILI), with testing for laboratory confirmation of a proportion of cases at the discretion of general practitioners. The aim of this study was to evaluate the consistency of sentinel general practitioners' swabbing practice within and between influenza seasons. Aggregated, weekly, non-identified data for May to October each year from 2007 to 2014 were used to calculate the proportion of patients presenting with ILI (defined as cough, fever and fatigue), proportion of ILI patients swabbed and proportion of swabs positive for influenza.

View Article and Find Full Text PDF

Background: A record number of laboratory-confirmed influenza cases were notified in Australia in 2015, during which type A(H3) and type B Victoria and Yamagata lineages co-circulated. We estimated effectiveness of the 2015 inactivated seasonal influenza vaccine against specific virus lineages and clades.

Methods: Three sentinel general practitioner networks conduct surveillance for laboratory-confirmed influenza amongst patients presenting with influenza-like illness in Australia.

View Article and Find Full Text PDF

Background: During the first wave of influenza A(H1N1)pdm09 in Victoria, Australia the rapid increase in notified cases and the high proportion with relatively mild symptoms suggested that community transmission was established before cases were identified. This lead to the hypothesis that those with low-level infections were the main drivers of the pandemic.

Methods: A deterministic susceptible-infected-recovered model was constructed to describe the first pandemic wave in a population structured by disease severity levels of asymptomatic, low-level symptoms, moderate symptoms and severe symptoms requiring hospitalisation.

View Article and Find Full Text PDF

Background: The influenza virus undergoes frequent antigenic drift, necessitating annual review of the composition of the influenza vaccine. Vaccination is an important strategy for reducing the impact and burden of influenza, and estimating vaccine effectiveness (VE) each year informs surveillance and preventative measures. We aimed to describe the influenza season and to estimate the effectiveness of the influenza vaccine in Victoria, Australia, in 2013.

View Article and Find Full Text PDF

Duration of viral shedding following infection is an important determinant of disease transmission, informing both control policies and disease modelling. We undertook a systematic literature review of the duration of influenza A(H1N1)pdm09 virus shedding to examine the effects of age, severity of illness and receipt of antiviral treatment. Studies were identified by searching the PubMed database using the keywords 'H1N1', 'pandemic', 'pandemics', 'shed' and 'shedding'.

View Article and Find Full Text PDF

Background: The Victorian Government Department of Health funded a diphtheria, tetanus and acellular pertussis vaccine for parents of infants from June 2009 to June 2012 as part of a cocooning strategy for the control of pertussis. The aim of this study was to assess parents' attitudes and awareness of the vaccination program, and to estimate vaccine uptake.

Methods: A cross-sectional survey of 253 families with a child born in the first quarter of 2010 residing within five metropolitan and four rural local government areas in Victoria was conducted.

View Article and Find Full Text PDF

Background: Victoria was the first state in Australia to experience community transmission of influenza A(H1N1)pdm09. We undertook a descriptive epidemiological analysis of the first 1,000 notified cases to describe the epidemic associated with school children and explore implications for school closure and antiviral distribution policy in revised pandemic plans.

Methods: Records of the first 1,000 laboratory-confirmed cases of influenza A(H1N1)pdm09 notified to the Victorian Government Department of Health between 20 May and 5 June 2009 were extracted from the state's notifiable infectious diseases database.

View Article and Find Full Text PDF

Background: The Australian state of Victoria, with 5.2 million residents, enforced home quarantine during a H1N1 pandemic in 2009. The strategy was targeted at school children.

View Article and Find Full Text PDF

Background: Influenza vaccines are licensed annually based on immunogenicity studies. We used five sequential years of data to estimate influenza vaccine effectiveness (VE), the critical outcome in the field.

Methods: Between 2007 and 2011, we performed annual prospective test-negative design case-control studies among adults aged 20-64 years recruited from sentinel general practices in the Australian state of Victoria.

View Article and Find Full Text PDF